PAK Kinase Regulates Rac GTPase and is a Potential Target in Human Schwannomas

Overview

Journal Exp Neurol

Specialty Neurology

Date 2009 May 5

PMID 19409384

Citations 24

Authors

Christine Flaiz

Jonathan Chernoff

Sylwia Ammoun

Jeffrey R Peterson

Clemens O Hanemann

Affiliations

Soon will be listed here.

Abstract

Merlin loss causes benign tumours of the nervous system, mainly schwannomas and meningiomas. Schwannomas show enhanced Rac1 and Cdc42 activity, the p21-activated kinase 2 (PAK2) activation and increased ruffling and cell adhesion. PAK regulates activation of merlin. PAK has been proposed as a potential therapeutic target in schwannomas. However where PAK stands in the Rac pathway is insufficiently characterised. We used a novel small-molecule PAK inhibitor, IPA-3, to investigate the role of PAK activation on Rac1/Cdc42 activity, cell spreading and adhesion in human primary schwannoma and Schwann cells. We show that IPA-3 blocks activation of PAK2 at Ser192/197 that antagonises PAK's interaction with Pix. Accordingly, Pix-mediated Rac1 activation is decreased in IPA-3 treated schwannoma cells, indicating that PAK acts upstream of Rac. We show that this Rac activation at the level of focal adhesions in schwannoma cells is essential for cell spreading and adhesion in Schwann and schwannoma cells.

Citing Articles

Regulation of Vascular Injury and Repair by P21-Activated Kinase 1 and P21-Activated Kinase 2: Therapeutic Potential and Challenges.

Han C, Zhu M, Liu Y, Yang Y, Cheng J, Li P Biomolecules. 2025; 14(12.

PMID: 39766303 PMC: 11674331. DOI: 10.3390/biom14121596.

Rac1 GTPase Regulates the βTrCP-Mediated Proteolysis of YAP Independently of the LATS1/2 Kinases.

Palanivel C, Somers T, Gabler B, Chen Y, Zeng Y, Cox J Cancers (Basel). 2024; 16(21).

PMID: 39518045 PMC: 11545309. DOI: 10.3390/cancers16213605.

Targeting the Hippo pathway in Schwann cells ameliorates peripheral nerve degeneration via a polypharmacological mechanism.

Chung H, Nguyen T, Lee J, Huh Y, Ko S, Lim H Neurotherapeutics. 2024; 21(6):e00458.

PMID: 39384453 PMC: 11585884. DOI: 10.1016/j.neurot.2024.e00458.

Genetic mutation and immune infiltration in embryonal tumor with multilayered rosettes.

Zou Y, Liu Y, Liu H, Feng J, Gao P, Ma H Childs Nerv Syst. 2024; 40(9):2685-2696.

PMID: 38802706 DOI: 10.1007/s00381-024-06461-1.

Potential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects.

Zhang Y, Long J, Ren J, Huang X, Zhong P, Wang B Front Oncol. 2021; 11:731441.

PMID: 34646772 PMC: 8503266. DOI: 10.3389/fonc.2021.731441.

References

Hanemann C, Bartelt-Kirbach B, Diebold R, Kampchen K, Langmesser S, Utermark T . Differential gene expression between human schwannoma and control Schwann cells. Neuropathol Appl Neurobiol. 2006; 32(6):605-14. DOI: 10.1111/j.1365-2990.2006.00769.x. View

Rosenbaum C, Kluwe L, Mautner V, Friedrich R, Muller H, Hanemann C . Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients. Neurobiol Dis. 1998; 5(1):55-64. DOI: 10.1006/nbdi.1998.0179. View

Deacon S, Beeser A, Fukui J, Rennefahrt U, Myers C, Chernoff J . An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chem Biol. 2008; 15(4):322-31. PMC: 4353635. DOI: 10.1016/j.chembiol.2008.03.005. View

Bokoch G . Biology of the p21-activated kinases. Annu Rev Biochem. 2003; 72:743-81. DOI: 10.1146/annurev.biochem.72.121801.161742. View

Utermark T, Kaempchen K, Hanemann C . Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins. Brain Pathol. 2003; 13(3):352-63. PMC: 8095832. DOI: 10.1111/j.1750-3639.2003.tb00034.x. View

Benninger Y, Thurnherr T, Pereira J, Krause S, Wu X, Chrostek-Grashoff A . Essential and distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous system development. J Cell Biol. 2007; 177(6):1051-61. PMC: 2064365. DOI: 10.1083/jcb.200610108. View

Manser E, Loo T, Koh C, Zhao Z, Chen X, Tan L . PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol Cell. 1998; 1(2):183-92. DOI: 10.1016/s1097-2765(00)80019-2. View

Nakai Y, Zheng Y, MacCollin M, Ratner N . Temporal control of Rac in Schwann cell-axon interaction is disrupted in NF2-mutant schwannoma cells. J Neurosci. 2006; 26(13):3390-5. PMC: 6673872. DOI: 10.1523/JNEUROSCI.4865-05.2006. View

Ten Klooster J, Jaffer Z, Chernoff J, Hordijk P . Targeting and activation of Rac1 are mediated by the exchange factor beta-Pix. J Cell Biol. 2006; 172(5):759-69. PMC: 2063707. DOI: 10.1083/jcb.200509096. View

10.

Flaiz C, Ammoun S, Biebl A, Hanemann C . Altered adhesive structures and their relation to RhoGTPase activation in merlin-deficient Schwannoma. Brain Pathol. 2008; 19(1):27-38. PMC: 8094867. DOI: 10.1111/j.1750-3639.2008.00165.x. View

11.

Flaiz C, Utermark T, Parkinson D, Poetsch A, Hanemann C . Impaired intercellular adhesion and immature adherens junctions in merlin-deficient human primary schwannoma cells. Glia. 2008; 56(5):506-15. DOI: 10.1002/glia.20629. View

12.

Beeser A, Jaffer Z, Hofmann C, Chernoff J . Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors. J Biol Chem. 2005; 280(44):36609-15. DOI: 10.1074/jbc.M502306200. View

13.

Kaempchen K, Mielke K, Utermark T, Langmesser S, Hanemann C . Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells. Hum Mol Genet. 2003; 12(11):1211-21. DOI: 10.1093/hmg/ddg146. View

14.

Zhao Z, Manser E . PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation. Biochem J. 2004; 386(Pt 2):201-14. PMC: 1134783. DOI: 10.1042/BJ20041638. View

15.

Shaw R, Paez J, Curto M, Yaktine A, Pruitt W, Saotome I . The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell. 2001; 1(1):63-72. DOI: 10.1016/s1534-5807(01)00009-0. View

16.

Hirokawa Y, Tikoo A, Huynh J, Utermark T, Hanemann C, Giovannini M . A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor. Cancer J. 2004; 10(1):20-6. DOI: 10.1097/00130404-200401000-00006. View

17.

Thaxton C, Lopera J, Bott M, Fernandez-Valle C . Neuregulin and laminin stimulate phosphorylation of the NF2 tumor suppressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways. Oncogene. 2007; 27(19):2705-15. DOI: 10.1038/sj.onc.1210923. View

18.

Utermark T, Schubert S, Hanemann C . Rearrangements of the intermediate filament GFAP in primary human schwannoma cells. Neurobiol Dis. 2005; 19(1-2):1-9. DOI: 10.1016/j.nbd.2004.11.015. View

19.

Ridley A, Hall A . The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992; 70(3):389-99. DOI: 10.1016/0092-8674(92)90163-7. View

20.

Obermeier A, Ahmed S, Manser E, YEN S, Hall C, Lim L . PAK promotes morphological changes by acting upstream of Rac. EMBO J. 1998; 17(15):4328-39. PMC: 1170766. DOI: 10.1093/emboj/17.15.4328. View